224 related articles for article (PubMed ID: 36982738)
1. Molecular Analysis of SARS-CoV-2 Spike Protein-Induced Endothelial Cell Permeability and vWF Secretion.
Guo Y; Kanamarlapudi V
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982738
[TBL] [Abstract][Full Text] [Related]
2. Gene silencing of endothelial von Willebrand factor reduces the susceptibility of human endothelial cells to SARS-CoV-2 infection.
Furini G; De Carli A; Fonnesu R; Spezia PG; Scebba F; Pistello M; Lai M; Lionetti V
FEBS J; 2023 Sep; 290(17):4300-4315. PubMed ID: 37098810
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 spike protein-mediated cell signaling in lung vascular cells.
Suzuki YJ; Nikolaienko SI; Dibrova VA; Dibrova YV; Vasylyk VM; Novikov MY; Shults NV; Gychka SG
Vascul Pharmacol; 2021 Apr; 137():106823. PubMed ID: 33232769
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
[TBL] [Abstract][Full Text] [Related]
5. Spike Proteins of SARS-CoV-2 Induce Pathological Changes in Molecular Delivery and Metabolic Function in the Brain Endothelial Cells.
Kim ES; Jeon MT; Kim KS; Lee S; Kim S; Kim DG
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696455
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Spike Protein Destabilizes Microvascular Homeostasis.
Panigrahi S; Goswami T; Ferrari B; Antonelli CJ; Bazdar DA; Gilmore H; Freeman ML; Lederman MM; Sieg SF
Microbiol Spectr; 2021 Dec; 9(3):e0073521. PubMed ID: 34935423
[TBL] [Abstract][Full Text] [Related]
7. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites.
Qiao B; Olvera de la Cruz M
ACS Nano; 2020 Aug; 14(8):10616-10623. PubMed ID: 32806067
[TBL] [Abstract][Full Text] [Related]
8. Probing structural basis for enhanced binding of SARS-CoV-2 P.1 variant spike protein with the human ACE2 receptor.
Lata S; Akif M
J Cell Biochem; 2022 Jul; 123(7):1207-1221. PubMed ID: 35620980
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Spike Protein 1 Activates Microvascular Endothelial Cells and Complement System Leading to Platelet Aggregation.
Perico L; Morigi M; Galbusera M; Pezzotta A; Gastoldi S; Imberti B; Perna A; Ruggenenti P; Donadelli R; Benigni A; Remuzzi G
Front Immunol; 2022; 13():827146. PubMed ID: 35320941
[TBL] [Abstract][Full Text] [Related]
10. Computational Alanine Scanning and Structural Analysis of the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Complex.
Laurini E; Marson D; Aulic S; Fermeglia M; Pricl S
ACS Nano; 2020 Sep; 14(9):11821-11830. PubMed ID: 32833435
[TBL] [Abstract][Full Text] [Related]
11. Mutation informatics: SARS-CoV-2 receptor-binding domain of the spike protein.
Verma S; Patil VM; Gupta MK
Drug Discov Today; 2022 Oct; 27(10):103312. PubMed ID: 35787481
[TBL] [Abstract][Full Text] [Related]
12. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier.
Buzhdygan TP; DeOre BJ; Baldwin-Leclair A; Bullock TA; McGary HM; Khan JA; Razmpour R; Hale JF; Galie PA; Potula R; Andrews AM; Ramirez SH
Neurobiol Dis; 2020 Dec; 146():105131. PubMed ID: 33053430
[TBL] [Abstract][Full Text] [Related]
13. Molecular Basis of Mink ACE2 Binding to SARS-CoV-2 and Its Mink-Derived Variants.
Su C; He J; Han P; Bai B; Li D; Cao J; Tian M; Hu Y; Zheng A; Niu S; Chen Q; Rong X; Zhang Y; Li W; Qi J; Zhao X; Yang M; Wang Q; Gao GF
J Virol; 2022 Sep; 96(17):e0081422. PubMed ID: 36000849
[TBL] [Abstract][Full Text] [Related]
14. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2.
Liu Z; Xiao X; Wei X; Li J; Yang J; Tan H; Zhu J; Zhang Q; Wu J; Liu L
J Med Virol; 2020 Jun; 92(6):595-601. PubMed ID: 32100877
[TBL] [Abstract][Full Text] [Related]
15. Interfacial Water in the SARS Spike Protein: Investigating the Interaction with Human ACE2 Receptor and In Vitro Uptake in A549 Cells.
Singh AV; Kayal A; Malik A; Maharjan RS; Dietrich P; Thissen A; Siewert K; Curato C; Pande K; Prahlad D; Kulkarni N; Laux P; Luch A
Langmuir; 2022 Jul; 38(26):7976-7988. PubMed ID: 35736838
[TBL] [Abstract][Full Text] [Related]
16. Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding.
Byrnes JR; Zhou XX; Lui I; Elledge SK; Glasgow JE; Lim SA; Loudermilk RP; Chiu CY; Wang TT; Wilson MR; Leung KK; Wells JA
mSphere; 2020 Sep; 5(5):. PubMed ID: 32938700
[TBL] [Abstract][Full Text] [Related]
17. Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies.
Yi C; Sun X; Ye J; Ding L; Liu M; Yang Z; Lu X; Zhang Y; Ma L; Gu W; Qu A; Xu J; Shi Z; Ling Z; Sun B
Cell Mol Immunol; 2020 Jun; 17(6):621-630. PubMed ID: 32415260
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective.
Hosoki K; Chakraborty A; Sur S
J Allergy Clin Immunol; 2020 Aug; 146(2):285-299. PubMed ID: 32624257
[TBL] [Abstract][Full Text] [Related]
19. Static all-atom energetic mappings of the SARS-Cov-2 spike protein and dynamic stability analysis of "Up" versus "Down" protomer states.
Peters MH; Bastidas O; Kokron DS; Henze CE
PLoS One; 2020; 15(11):e0241168. PubMed ID: 33170884
[TBL] [Abstract][Full Text] [Related]
20. An angiotensin-converting enzyme-2-derived heptapeptide GK-7 for SARS-CoV-2 spike blockade.
Han S; Zhao G; Wei Z; Chen Y; Zhao J; He Y; He YJ; Gao J; Chen S; Du C; Wang T; Sun W; Huang Y; Wang C; Wang J
Peptides; 2021 Nov; 145():170638. PubMed ID: 34419496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]